These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34132839)
21. Fibrinolysis Shutdown in Severe COVID-19: Highly Prevalent but not Independently Predictive of Thrombosis or Poorer Outcomes. Littlejohn J; Vasovic LV; Cushing MM; Barie PS J Am Coll Surg; 2022 Jan; 234(1):97-98. PubMed ID: 35213468 [No Abstract] [Full Text] [Related]
22. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
23. COVAX Statement on WHO emergency use listing for AstraZeneca/Oxford COVID-19 vaccine. Saudi Med J; 2021 Mar; 42(3):344-345. PubMed ID: 33632917 [No Abstract] [Full Text] [Related]
24. Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia. Jacobson BF; Schapkaitz E; Mer M; Louw S; Haas S; Buller HR; Brenner B; Abdool-Carrim ATO; De Jong P; Hsu P; Jankelow D; Lebos M; Levy B; Radford H; Rowji P; Redman L; Sussman M; Van der Jagt D; Wessels PF; Williams PG; Society Of Thrombosis And Haemostasis OBOTSA S Afr Med J; 2021 Apr; 111(6):535-537. PubMed ID: 34382561 [TBL] [Abstract][Full Text] [Related]
25. [Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19]. Wolthers SA; Stenberg J; Nielsen HB; Stensballe J; Pedersen HP Ugeskr Laeger; 2021 Aug; 183(35):. PubMed ID: 34477089 [TBL] [Abstract][Full Text] [Related]
26. COVID vaccines and blood clots: what researchers know so far. Ledford H Nature; 2021 Aug; 596(7873):479-481. PubMed ID: 34429544 [No Abstract] [Full Text] [Related]
27. Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Dutta A; Ghosh R; Bhattacharya D; Bhat S; Ray A; Pandit A; Das S; Dubey S Diabetes Metab Syndr; 2021; 15(4):102184. PubMed ID: 34186376 [No Abstract] [Full Text] [Related]
28. [Temporary suspension of AstraZeneca's vaccine; a reconstruction]. Maas DPMSM; Kramers C; Smit HJCA; Middeldorp S; Helsloot I Ned Tijdschr Geneeskd; 2021 Apr; 165():. PubMed ID: 33914428 [TBL] [Abstract][Full Text] [Related]
29. Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy. Faranda D; Alberti T; Arutkin M; Lembo V; Lucarini V Chaos; 2021 Apr; 31(4):041105. PubMed ID: 34251248 [TBL] [Abstract][Full Text] [Related]
30. [COVID-19 - The vaccine miracle must include strictness and caution]. Agut H Virologie (Montrouge); 2021 Jun; 25(3):141-147. PubMed ID: 34112629 [TBL] [Abstract][Full Text] [Related]
31. Fibrinolytic Shutdown in COVID-19 Is Likely a Misnomer. Lisman T Shock; 2021 Jun; 55(6):844-845. PubMed ID: 33989264 [No Abstract] [Full Text] [Related]
32. Do Corticosteroid Injections for the Treatment of Pain Influence the Efficacy of Adenovirus Vector-Based COVID-19 Vaccines? Lee H; Punt JA; Patel J; Stojanovic MP; Duszynski B; McCormick ZL; Pain Med; 2021 Jun; 22(6):1441-1464. PubMed ID: 33839780 [TBL] [Abstract][Full Text] [Related]
36. Prioritizing the First Doses of SARS-CoV-2 Vaccine to Save the Elderly: The Case Study of Italy. Pontrelli G; Cimini G; Roversi M; Gabrielli A; Salina G; Bernardi S; Rocchi F; Simonetti A; Giaquinto C; Rossi P; Sylos Labini F Front Public Health; 2021; 9():684760. PubMed ID: 34336771 [TBL] [Abstract][Full Text] [Related]
37. COVID-19 Vaccine Race: Analysis of Age-Dependent Immune Responses against SARS-CoV-2 Indicates that more than Just One Strategy May Be Needed. Jimenez M; Campillo NE; Canelles M Curr Med Chem; 2021; 28(20):3964-3979. PubMed ID: 33109026 [TBL] [Abstract][Full Text] [Related]
38. [What are the differences between the various covid-19 vaccines?]. Ligtenberg AJM; Brand HS Ned Tijdschr Tandheelkd; 2021 Jul; 128(epub ahead of print 2021):. PubMed ID: 34228411 [TBL] [Abstract][Full Text] [Related]
39. Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience. Bano F; Badugama B; Chandra D BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34257129 [TBL] [Abstract][Full Text] [Related]
40. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]